mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.3 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.033 |
0.3 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.3 |
mRNA |
BRD-K48334597 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.3 |
mRNA |
XL765 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.3 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.034 |
0.3 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
-0.036 |
0.3 |
mRNA |
AZD6244 |
FIMM |
pan-cancer |
AAC |
0.24 |
0.3 |
mRNA |
ETP-46464 |
CTRPv2 |
pan-cancer |
AAC |
0.042 |
0.3 |
mRNA |
S-Trityl-L-cysteine |
FIMM |
pan-cancer |
AAC |
0.24 |
0.3 |